(Q34981341)

5 August 2017

1 reference

title

Cardiac valvulopathy in the antiphospholipid syndrome (English)

1 reference

5 August 2017

2

Yehuda Shoenfeld

1 reference

5 August 2017

Shaul Lev

1

1 reference

5 August 2017

1 December 2002

1 reference

Clinical Reviews in Allergy & Immunology

5 August 2017

1 reference

5 August 2017

23

1 reference

5 August 2017

3

1 reference

5 August 2017

341-348

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:23:3:341

5 August 2017

0 references

cites work

Bacterial endocarditis complicating systemic lupus erythematosus

1 reference

12 December 2020

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

1 reference

12 December 2020

Two- and three-dimensional echocardiography in primary antiphospholipid syndrome: misdiagnosis as rheumatic valve disease

1 reference

12 December 2020

'Primary', 'secondary' and other variants of the antiphospholipid syndrome

1 reference

12 December 2020

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

1 reference

12 December 2020

Neurological disease associated with antiphospholipid antibodies

1 reference

12 December 2020

A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus.

1 reference

12 December 2020

Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules

1 reference

12 December 2020

Clinical diagnosis of cardiac involvement in systemic lupus erythematosus. A correlation of clinical and autopsy findings in thirty patients

1 reference

12 December 2020

Thrombotic skin disease as a marker of the anticardiolipin syndrome

1 reference

12 December 2020

Echocardiographic evaluation of patients with primary antiphospholipid syndrome

1 reference

12 December 2020

Clinically significant valvular heart disease in systemic lupus erythematosus

1 reference

12 December 2020

Valvular heart disease in the primary antiphospholipid syndrome

1 reference

12 December 2020

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

12 December 2020

Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients

1 reference

12 December 2020

The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies

1 reference

12 December 2020

Primary antiphospholipid syndrome and mitral valve thrombosis

1 reference

12 December 2020

Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies

1 reference

12 December 2020

Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus

1 reference

12 December 2020

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome

1 reference

12 December 2020

Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets

1 reference

12 December 2020

The heart in systemic lupus erythematosus

1 reference

12 December 2020

M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus

1 reference

12 December 2020

Assays for detection of antiphospholipid antibodies

1 reference

12 December 2020

High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome

1 reference

12 December 2020

Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment

1 reference

12 December 2020

Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome

1 reference

12 December 2020

Antiphospholipid antibodies, valvular heart disease and systemic lupus erythematosus

1 reference

12 December 2020

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

1 reference

12 December 2020

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

12 December 2020

Cardiovascular involvement in systemic lupus erythematosus

1 reference

12 December 2020

Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus

1 reference

12 December 2020

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

12 December 2020

Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease

1 reference

12 December 2020

Inhibition of phospholipid-dependent coagulation reactions by 'antiphospholipid antibodies': possible modes of action

1 reference

12 December 2020

Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.

1 reference

12 December 2020

High Prevalence of Anti-β2 Glycoprotein I Antibodies in Patients with Ischemic Heart Disease

1 reference

12 December 2020

The anticardiolipin syndrome

1 reference

12 December 2020

Recent advances in antiphospholipid antibody-related valvulopathies

1 reference

12 December 2020

Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group

1 reference

12 December 2020

The antiphospholipid syndrome: ten years on.

1 reference

12 December 2020

A reassessment of the antiphospholipid syndrome

1 reference

12 December 2020

Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies

1 reference

12 December 2020

Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus Erythematosus

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:23:3:341

1 reference

PubMed ID

12402416

Dimensions Publication ID

5 August 2017

1010541340

0 references

Fatcat ID

release_7imvv752p5g4ldujzlioiqjocm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7imvv752p5g4ldujzlioiqjocm

24 November 2022

mapped directly with Wikidata item

PubMed ID

12402416

1 reference

PubMed ID

12402416